IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.733
-0.087 (-10.59%)
Nov 21, 2024, 2:19 PM EST - Market open
IO Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 48 | 124 | 66 | 184 | - | - |
| Market Cap Growth | -25.53% | 86.88% | -64.06% | - | - | - |
| Enterprise Value | -24 | -39 | -82 | 268 | - | - |
| Last Close Price | 0.82 | 1.88 | 2.30 | 6.40 | - | - |
| PB Ratio | 0.75 | 0.93 | 0.48 | 0.87 | - | - |
| P/TBV Ratio | 0.95 | 0.93 | 0.48 | 0.87 | - | - |
| Debt / Equity Ratio | 0.03 | 0.02 | 0.02 | - | - | -5.89 |
| Quick Ratio | 4.99 | 9.18 | 13.50 | 20.73 | 1.61 | 0.84 |
| Current Ratio | 5.37 | 9.37 | 13.88 | 21.52 | 1.85 | 0.87 |
| Return on Equity (ROE) | -78.50% | -63.29% | -40.74% | -63.28% | -2127.56% | - |
| Return on Assets (ROA) | -45.91% | -37.78% | -23.87% | -22.61% | -84.12% | - |
| Return on Capital (ROIC) | -51.33% | -41.22% | -25.25% | -24.03% | -129.47% | - |
| Earnings Yield | -167.10% | -69.50% | -107.82% | -36.81% | - | - |
| FCF Yield | -58.18% | -91.16% | -22.12% | - | - |
| Buyback Yield / Dilution | -92.75% | -51.10% | -564.62% | -2346.74% | - | - |
| Total Shareholder Return | -92.75% | -51.10% | -564.62% | -2346.74% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.